Andropause
Andropause is a condition that is associated with the decrease in the male hormone testosterone. It is unlike menopause in that the decrease in testosterone and the development of symptoms is more gradual
Background
General Symptoms
- Sarcopenia (Loss of muscle mass)
- Osteoporosis
- Loss of Libido
- Constipation & Erective Dysfunction
- Mood Swings
- Sweat at Night Saggy Cheeks
Diagnosis
Improved mental health from elevated MCHC value by 4%.
Mean Corpuscular Haemoglobin Concentration (MCHC) refers to the average haemoglobin in the red blood cells. Haemoglobin is the protein molecule that carries oxygen to the tissues within the body.
During Treatment – November 2017
The normal range for MCHC is between 33-36 g/dl.
Before Treatment – July 2017
Patient’s MCHC is slightly under standard at 32.3 g/dl suggesting that he has signs of deficiency in Vitamin B12 which increases risk of having depression, paranoia and delusions, memory loss, incontinence, loss of taste and smell. Skerrett, 2013
After Treatment – October 2018
Patient’s MCHC has improved by 4% and return back to normal range.
Outcome
Normalising MCHC helps improving patient’s mental health.
Lowered risk of osteoporosis and heart disease by restoring Vitamin B & D balance.
Studies have shown that high homocysteine is a risk factor of heart disease. Ganguly, 2015; Wierzbicki, 2007
The maximum value of homocysteine for normal people is <8 μmol/l.
Before Treatment – July 2017
Patient’s homocysteine level is at 11.1 μmol/l exceeded almost 39% of maximum reference value. This suggests a high deficiency in Vitamin B, particularly Vitamin B12 and folic acid.
Besides, Patient’s low level of Vitamin D (22.5 ng/ml; normal range 30-80) increases the risk of osteoporosis.
During Treatment – November 2017
Patient’s homocysteine level is reduced by 26% after four months from 11.1 μmol/l to 8.2 μmol/l. While Patient’s Vitamin D is raised by 3.53 times.
Reduced inflammation by 50%
During Treatment – July 2017
Inflammation level is under good condition as patient’s level is at 0.4 mg/l which is within standard.
After Treatment – October 2018
Patient’s inflammation level improved by a reduction of 50%.
Treatment & Outcome
Aug 2017
4 types of oral supplements
Nov 2017
6 types of oral supplements
Oct 2018
10 types of oral supplements
1. Improved mental health from elevated MCHC by 4%.
2. Reduced risk of osteoporosis by raising Vit D 3.53 times.
3. Lowered risk of heart disease by reducing homocysteine 26%.
4. Inflammation level improved by a reduction of 50%.
5. All symptoms show signs of improvement.
Department of Health (2017) Men’s healthline – andropause
https://www.chp.gov.hk/en/static/80026.html
Ganguly, P., Alam, S.F. (2015) Role of homocysteine in the development of cardiovascular disease. Nutrition Journal. 14:6 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326479/
Schwarz, E.R., Phan, A., Willix, R.D. (2011) Andropause and the development of cardiovascular disease presentation – more than an epi-phenomenon. Journal of Geriatric Cardiology. 8(1):35-43 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3390065/
Skerrett, P.J. (2013) Vitamin B12 deficiency can be sneaky, harmful. Harvard Health Publishing. https://www.health.harvard.edu/blog/vitamin-b12-deficiency-can-be-sneaky-harmful- 201301105780
Singh, P. (2013) Andropause: Current concepts. Indian Journal of Endocrinology and Metabolism. 17: S621-629 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046605/
Wierzbicki, A.S. (2007) Homocysteine and cardiovascular disease: a review of the evidence. Diabetes & Vascular Diesease Research. 4(2):143-150 https://www.ncbi.nlm.nih.gov/pubmed/17654449
Advanced Cancer Research (2003) Natural killer cells and cancer
https://www.ncbi.nlm.nih.gov/pubmed/14710949
American Cancer Society (2016) Viruses that can lead to cancer https://www.cancer.org/cancer/cancer-causes/infectious-agents/infections-that-can-lead-to-cancer/viruses.html
Billett, H.H. (1990) Haemoglobin and haematocrit. Clinical methods: the history, physical, and laboratory examinations
https://www.ncbi.nlm.nih.gov/books/NBK259/
Campo, E., Swerdlow, S.H., Harris, N.L., Pileri, S., Stein, H., Jaffe, E.S. (2011) The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Journal of American Society of Hematology. 117(19):5019-5032
https://www.ncbi.nlm.nih.gov/pmc/articles/
PMC3109529/#
Coy, J.F. (2017) EDIM-TKTL1/Apo10 blood test: an innate immune system based liquid biopsy for the early detection, characterization and targeted treatment of cancer. International Journal of Molecular Sciences. 20:18(4)
https://www.ncbi.nlm.nih.gov/pubmed/28425973
Encyclopaedia Britannica (2019) Neurotransmitter
https://www.britannica.com/science/
neurotransmitter
Ginaldi, L., Martinis, M.D., Matutes, E., Farahat, N., Morilla, R., Catovsky, D. (1998) Levels of expression of CD19 and CD20 in chronic B cell leukaemias. Journal Clinica of Pathology. 51:364-369
https://www.ncbi.nlm.nih.gov/pmc/articles/
PMC500695/pdf/jclinpath00266-0020.pdf
Grimm, M., Schmitt, S., Teriete, P., Biegner, T., Stenzl, A., Hennenlotter, J., Muhs, H.J., Munz, A., Nadtotschi, T., Konig, K., Sanger, J., Feyen, O., Hofmann, H., Reinert, S., Coy, J.F. (2013) A biomarker based detection and characterization of carcinomas exploiting two fundamental biophysical mechanisms in mammalian cells. BMC Cancer. 4:13:569 https://www.ncbi.nlm.nih.gov/pubmed/24304513
Ko, Y.H. (2015) EBV and human cancer. Experimental & Molecular Medicine. 47(1):e130 https://www.ncbi.nlm.nih.gov/pmc/articles/
PMC4314581/
Lange, C.A.K, Tisch-Rottensteiner, J., Bohringer, D., Gottfried, M., Schwartzkopff, J., Auw-Hadrich, C. (2012) Enhanced TKTL1 expression in malignant tumours of the ocular adnexa predicts clinical outcome. Ophthalmology. 119(9):1924- 9
https://www.ncbi.nlm.nih.gov/pubmed/22658715
Madu, A.J., Ocheni, S., Ibegbulam, OG., Aguwa, E.N., Madu, K.A. (2013) Pattern of CD4 T-lymphocyte values in cancer patients on cytotoxic therapy. Annals of Medical and Health Science Research. 3(4):498-503
https://www.ncbi.nlm.nih.gov/pmc/articles/
PMC3868113/
Martel, J. (2018) Healthline: T cell count
https://www.healthline.com/health/t-cell-count
National Cancer Institute (2018) NCI Dictionary of Cancer Terms- cancer
https://www.cancer.gov/publications/
dictionaries/cancer-terms/def/cancer
National Cancer Institute (2018) NCI Dictionary of Cancer Terms – complete blood count
https://www.cancer.gov/publications/
dictionaries/cancer-terms/def/complete-blood-count
National Cancer Institute (2018) NCI Dictionary of Cancer Terms – malignancy
https://www.cancer.gov/publications/
dictionaries/cancer-terms/def/malignancy
National Cancer Institute (2018) NCI Dictionary of Cancer Terms – thrombocytes
https://www.cancer.gov/publications/
dictionaries/cancer-terms/def/thrombocyte
National Kidney Foundation (2017) Creatinine: what is it?
https://www.kidney.org/atoz/content/what-creatinine
Ollila, J. & Vihinen, M (2005) B cells. The International Journal of Biochemistry & Cell Biology. 37(3):518-23
https://www.ncbi.nlm.nih.gov/pubmed/
15618007
Thompson, M.P. & Kurzrock, R. (2004) Epstein-Barr virus and cancer. Clinical Cancer Research. 10(3):803-21 https://www.ncbi.nlm.nih.gov/pubmed/
14871955
Troussard, X., Cornet, E. (2017) Hairy cell leukemia 2018: update on diagnosis, risk stratification, and treatment. American Journal of Hematology 92(12):1382-1390
https://www.ncbi.nlm.nih.gov/pmc/articles/
PMC5698705/
Wu, J., Lanier, L.L. (2003) Natural killer cells and cancer. Advances in Cancer Research. 90:127-56 https://www.ncbi.nlm.nih.gov/pubmed/
14710949
University of Rochester Medical Center (2019) What are red blood cells?
https://www.urmc.rochester.edu/encyclopedia/
content.aspx?ContentID=34&ContentTypeID=160
Vazzana, N., Spadano, R., Sestili, S., Toto, V., Falorio, S., Catinella, V., Angrilli, F., Dragani, A. (2004) Hairy cell leukaemia and venous thromboembolism: a case report and review of the literature. Blood Transfusion. 12(2):276- 279
https://www.ncbi.nlm.nih.gov/pmc/articles/
PMC4039712/
Viver, E., Tomasello, E., Baratin, M., Walzer, T., Ugolini, S. (2008) Functions of natural killer cells. Nature Immunology. 9(5):503-10
https://www.ncbi.nlm.nih.gov/pubmed/
18425107